

NCT03256864 Raw comparison:

Summary:
CHIA has 11 criteria while your personal folder has 15 criteria
Total found criteria: 11/11
Total not Found: 0/11
Total Extra: 4
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Liver Transplant Recipients have received liver    │ Liver Transplant Recipients have received liver    │
│ transplantations for at least 6+1 months prior to  │ transplantations for at least 6+1 months prior to  │
│ enrollment                                         │ enrollment                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Liver Transplant Recipients have no acute          │ Liver Transplant Recipients have no acute          │
│ rejection episodes within 3 months prior to the    │ rejection episodes within 3 months prior to the    │
│ enrollment and are clinically stable               │ enrollment and are clinically stable               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Liver Transplant Recipients have been treated with │ Liver Transplant Recipients have been treated with │
│ twice-daily regimen of tacrolimus(TAC) plus        │ twice-daily regimen of tacrolimus(TAC) plus        │
│ everolimus(EVR) and TAC and EVR trough levels have │ everolimus(EVR) and TAC and EVR trough levels have │
│ stayed within targeted ranges for at least 6 weeks │ stayed within targeted ranges for at least 6 weeks │
│ prior to enrollment                                │ prior to enrollment                                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Provide written informed consent prior to          │ Provide written informed consent prior to          │
│ inclusion                                          │ inclusion                                          │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Liver transplant recipients who are 18-65 years of │ Liver transplant recipients who are 18-65 years of │
│ age of a primary liver transplant                  │ age of a primary liver transplant                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Allograft functioning at an acceptable level as    │ Allograft functioning at an acceptable level as    │
│ defined by the AST ALT Total Bilirubin levels =3   │ defined by the AST ALT Total Bilirubin levels ≤3   │
│ times ULN prior to enrollment                      │ times ULN prior to enrollment                      │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Abbreviated MDRD eGFR = 30 mL/min/1 73m2           │ Abbreviated MDRD eGFR ≥ 30 mL/min/1 73m2 Key       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients who are recipients of multiple solid      │ Patients who are recipients of multiple solid      │
│ organ or islet cell tissue transplants or have     │ organ or islet cell tissue transplants or have     │
│ previously received an organ or tissue transplant  │ previously received an organ or tissue transplant  │
│ Patients who have a combined liver-kidney          │ Patients who have a combined liver-kidney          │
│ transplant                                         │ transplant                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of malignancy of any organ system (other   │ History of malignancy of any organ system (other   │
│ than localized basal cell carcinoma of the skin)   │ than localized basal cell carcinoma of the skin)   │
│ treated or untreated within the past 5 years       │ treated or untreated within the past 5 years       │
│ regardless of whether there is evidence of local   │ regardless of whether there is evidence of local   │
│ recurrence or metastases                           │ recurrence or metastases                           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Existence of any surgical medical or mental        │ Existence of any surgical medical or mental        │
│ conditions other than the current transplantation  │ conditions other than the current transplantation  │
│ which in the opinion of the investigator might     │ which in the opinion of the investigator might     │
│ interfere with the objectives of the study         │ interfere with the objectives of the study         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Pregnant or nursing (lactating) women              │ Pregnant or nursing (lactating) women              │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═════════════════════════════════════════════════════════════════════════════════════════════════════╕
│ Extra Personal Criteria                                                                             │
╞═════════════════════════════════════════════════════════════════════════════════════════════════════╡
│ Must have maximum age of 65 Years                                                                   │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Stable liver transplant recipients are eligible for inclusion in this study and have to fulfill all │
│ of the following criteria                                                                           │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Must have minimum age of 18 Years                                                                   │
├─────────────────────────────────────────────────────────────────────────────────────────────────────┤
│ Patients fulfilling any of the following criteria are not eligible for inclusion in this study      │
╘═════════════════════════════════════════════════════════════════════════════════════════════════════╛